Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Code of Conduct

Listed below are links to the various Codes of Conduct that Trovagene operates under.

Code of Business Conduct and Ethics

Cardiff Oncology's Board of Directors approved Revision 02 of the Business Code of Conduct and Ethics effective as of December 05, 2018.